I guess you haven't been paying attention. HGEN, one of our big clients, was denied FDA EUA for their Covid drug Lenzilumab, which we produce for them. It's always something with this POS!
HI! ... IT could be the Affiliation or A ssociation with HGEN and the BUY ON RUMOR, SELL ON NEWS AFFECT, DESPITE the recent selloff coming into earnings call .. TOTAL OVER REACTION ON BOTH SECURITIES IMHO ... THE FDA IS BEYOND CORRUPT PROTECTING THEIR VAX COMPANIES vs UPCOMING THERAPEUTICS THAT HAVE GREAT EFFICACY ... WE WILL REBOUND STRONGLY ON THE GREAT QUARTER AND PROSPECT NEWS IMHO ......
Are we being punished early for HGEN. Are they that large of a customer to warrant a sell off after what appeared to be a great Q. Beat the street , Improved margins, strong backlog, increased guidance. What am I missing. What is unknown?
News 
Market Data 
Discover 
